Comprehensive M&A data with integrated detailed company information

Repligen to snap up EMT
Posted on Tuesday, 30 June 2020 07:05
Repligen has agreed to buy US-based Engineered Molding Technology (EMT), a manufacturer of single-use silicon assemblies and components, for an undisclosed sum.

The deal is due to complete during the acquiror’s third quarter of 2020.

Headquartered in New York, EMT makes a range of silicon assemblies and components used for the manufacturing of biologic drugs.

Its offerings include tri-clamp ends and tubes, as well as hoses and bottle stoppers which are needed for various biopharmaceutical applications.

The group operates a 20,000 square foot manufacturing facility, which comprises clean rooms for packaging and production.

Repligen’s chief executive, Tony J Hunt, said: “The acquisition of EMT expands our line of single-use ProConnex flow paths, streamlines our supply chain for ATF [alternating tangential flow], and gives us more flexibility as we scale and expand our single-use and systems portfolios.”

Furthermore, the deal will also allow the buyer to offer its bioprocessing customers faster lead-times on single-use flow path services and provide complete filtration and chromatography offerings to biopharmaceutical and contract manufacturing organisations.

Michael Pandori, co-founder of the target, said: “For EMT, this means taking our products global, expanding our commercial footprint and integrating select EMT technologies into Repligen product lines while continuing to innovate.”

Located in Massachusetts, the buyer develops materials used to make biologic drugs.

Repligen operates sites across the US, Germany and Sweden and its products are marketed through a direct commercial organisation worldwide, including in Europe and Asia.

Zephyr, the M&A database published by Bureau van Dijk, shows there have been 325 deals targeting plastics and rubber products manufacturers announced globally in 2020 to date.

In the largest of these, OMV agreed to increase its stake in Austria’s Borealis from 36.0 per cent to 75.0 per cent for EUR 4.68 billion.

Sailun Group, Nokian Renkaat and Vectorply, among other companies, were also targeted in this sector.

© Zephus Ltd